What House expands efforts to make Paxlovid, a highly effective COVID drug, available to more pharmacies; and seeks more funding for treatments

WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk of hospital admission...

More U.S. children were hospitalized for COVID during omicron; most were unvaccinated--CDC survey .

U.S. FDA approves Gilead's COVID-19 drug for young children

New Ebola outbreak in the Democratic Republic of the Congo

Case study: Analysis of Nebraska's surprisingly effective response to Covid pandemic

U.S. States cut back on Covid-19 data reporting, making trends harder to track

In the U.S., millions of COVID-19 shots set to go to waste as vaccine rollout slows

China: Beijing begins mass testing and partial lockdowns touching off food buying spree

CDC fhas a simple interactive tool to tell when to test yourself and how long to quarantine if you're exposed to COVID.

Covid was the third leading cause of death in the U.S. last year, trailing only heart disease and cancer

AMA primer on what doctors wish patients knew about the BA.2 Omicron subvariant

What doctors wish patients knew about the BA.2 Omicron subvariant

With the rolling back of mask requirements and physical distancing, many people have been on a search for a new normal. But there is still reason to be cautious. The highly transmissible and contagious BA.2 Omicron subvariant—dubbed “stealth” Omicron—is now the dominant strain in the United States, causing more than 85% of all COVID-19 cases, according to the Centers for Disease Control and Prevention (CDC). This has led to more questions.

Based on the CDC’s genomic surveillance, the BA.2 or stealth Omicron subvariant is responsible for most new SARS-CoV-2 infections in the U.S. BA.2 is a subvariant of the original SARS-CoV-2 Omicron variant (B.1.1.529), along with BA.1.1 and BA.3.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Overview: Asia developments, Shanghai, Hong Hong, Singapore, Thailand

EU committee backs Pfizer booster shot, WHO endorses Pfizer antiviral treatment

Vaccinations could have prevented a fourth of US COVID-19 deaths: new analysis

Pages

Subscribe to Global RSS
howdy folks